Docetaxel liposomal - Sun Pharma Advanced Research CompanyAlternative Names: DICN; Docetaxel injection concentrate for nanodispersion; Docetaxel nanodispersion - Sun Pharma Advanced Research Company; Liposome-encapsulated docetaxel - Sun Pharma Advanced Research Company
Latest Information Update: 09 Sep 2016
At a glance
- Originator Sun Pharma Advanced Research Company
- Class Antineoplastics; Small molecules; Taxanes
- Mechanism of Action Tubulin inhibitors; Tubulin polymerisation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Non-small cell lung cancer; Solid tumours
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 30 Jun 2012 Phase-I clinical trials in Non-small cell lung cancer in India (IV)